IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects

Oxidized LDL to autoantibodies against oxLDL ratio – The new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients

(2012) Krystyna Pawlak et al.   ATHEROSCLEROSIS

Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue

(2012) M Zeyda et al.   INTERNATIONAL JOURNAL OF OBESITY

Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes?

(2012) Ashley M. Miller et al.   PLoS One

Inflammatory Mechanisms in Obesity

(2011) Margaret F. Gregor et al.   Annual Review of Immunology

IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival

(2011) H. R. Turnquist et al.   JOURNAL OF IMMUNOLOGY

Vascular biology of metabolic syndrome

(2011) Daynene Vykoukal et al.   JOURNAL OF VASCULAR SURGERY

The IL-33/ST2 pathway — A new therapeutic target in cardiovascular disease

(2011) Ashley M. Miller et al.   PHARMACOLOGY & THERAPEUTICS

Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice

(2010) Ashley M. Miller et al.   CIRCULATION RESEARCH

IL-33 Reduces Macrophage Foam Cell Formation

(2010) J. E. McLaren et al.   JOURNAL OF IMMUNOLOGY

Adaptive immunity and atherosclerosis

(2009) John Andersson et al.   CLINICAL IMMUNOLOGY

Obesity, Inflammation, and Insulin Resistance – A Mini-Review

(2009) Maximilian Zeyda et al.   GERONTOLOGY

Obesity, inflammation, and atherosclerosis

(2009) Viviane Z. Rocha et al.   Nature Reviews Cardiology

Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis

(2008) M. Sakashita et al.   CLINICAL AND EXPERIMENTAL ALLERGY

IL-33 reduces the development of atherosclerosis

(2008) Ashley M. Miller et al.   JOURNAL OF EXPERIMENTAL MEDICINE